Invivyd Inc (IVVD)
2.455
+0.02
(+1.03%)
USD |
NASDAQ |
May 15, 15:58
Invivyd Total Liabilities (Quarterly): 36.97M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 36.97M |
December 31, 2023 | 51.71M |
September 30, 2023 | 28.42M |
June 30, 2023 | 33.85M |
March 31, 2023 | 23.82M |
December 31, 2022 | 27.20M |
September 30, 2022 | 47.30M |
Date | Value |
---|---|
June 30, 2022 | 69.77M |
March 31, 2022 | 96.88M |
December 31, 2021 | 62.07M |
September 30, 2021 | 53.06M |
June 30, 2021 | 542.62M |
March 31, 2021 | 198.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
23.82M
Minimum
Mar 2023
542.62M
Maximum
Jun 2021
97.84M
Average
51.71M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 108.69M |
Viking Therapeutics Inc | 33.63M |
Stoke Therapeutics Inc | 64.84M |
180 Life Sciences Corp | 5.387M |
MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 215.47M |
Shareholders Equity (Quarterly) | 178.50M |